04/24/2024 3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024 7:43 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024 3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
|
04/02/2024 3:48 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 3:45 PM | Biora Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 5:29 PM | Biora Therapeutics (Subject) Context Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
03/11/2024 7:11 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:43 PM | ARMISTICE CAPITAL, LLC (Filed by) Biora Therapeutics (Subject)
| Form SC 13G/A | |
01/16/2024 4:20 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/01/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
12/22/2023 4:19 PM | Biora Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/20/2023 3:29 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:35 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
12/18/2023 7:06 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 4:25 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 5:06 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/13/2023 5:04 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 5:01 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 4:19 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 3:15 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:15 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/19/2023 7:06 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 3:22 PM | Biora Therapeutics (Issuer) dEsparbes Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:27 PM | Biora Therapeutics (Issuer) NEUMANN CLARKE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 3:33 PM | Biora Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/16/2023 3:07 PM | Biora Therapeutics (Issuer) Kotzin Brian L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:30 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 7:00 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
06/13/2023 7:02 AM | Biora Therapeutics (Filer)
| Form 424B5 | |